Peter Rasmussen
Comptroller/Controller/Auditor bei ASCENDIS PHARMA A/S
Vermögen: 59 107 $ am 31.03.2024
Profil
Peter Rasmussen currently works at Ascendis Pharma A, as Chief Accounting Officer & VP-Finance from 2016.
Mr. Rasmussen also formerly worked at Veloxis Pharmaceuticals A, as Head-Finance from 2007 to 2008 and AdvanDx, Inc., as Chief Financial Officer from 2008 to 2012.
Mr. Rasmussen received his graduate degree from Copenhagen Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ASCENDIS PHARMA A/S
0,00% | 31.12.2023 | 391 ( 0,00% ) | 59 107 $ | 31.03.2024 |
Aktive Positionen von Peter Rasmussen
| Unternehmen | Position | Beginn |
|---|---|---|
| ASCENDIS PHARMA A/S | Comptroller/Controller/Auditor | 01.03.2014 |
Ehemalige bekannte Positionen von Peter Rasmussen
| Unternehmen | Position | Ende |
|---|---|---|
AdvanDx, Inc.
 AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Director of Finance/CFO | 01.08.2012 |
| VELOXIS PHARMACEUTICALS A/S | Director of Finance/CFO | 01.01.2008 |
Ausbildung von Peter Rasmussen
| Copenhagen Business School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASCENDIS PHARMA A/S | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
AdvanDx, Inc.
AdvanDx, Inc. Medical SpecialtiesHealth Technology AdvanDx, Inc. provides advanced molecular diagnostic products for the prevention, diagnosis and treatment of life-threatening, bacterial infections. Its products include QuickFISH BC Tests, PNA FISH Tests, ASR PNA Probes, starter system, accessories and package inserts. The firm offers diagnostic solutions that include antimicrobial stewardship, blood culture contamination, staphylococcal bacteremia, enterococcal bacteremia, gram-negative bacteremia and candidemia. The company was founded by Henrik Stender and Thais T. Johansen in 2002 and is headquartered in Woburn, MA. | Health Technology |
